What is DaShenLin Pharmaceutical Group Co FCF Yield %?
DaShenLin Pharmaceutical Group CoSHSE:603233 +0.88%95 FCF Yield % is 20.61 as of Jul. 06, 2026, which is 482% above its 10-year median of 3.54. GuruFocus rates SHSE:603233 with a GF Score™ of 95/100 and a GF Value™ of ¥18.75 (Fairly Valued). The stock has 4 warning signs investors should review. Among 681 Healthcare Providers & Services companies, DaShenLin Pharmaceutical Group Co ranks better than 92.22% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
SHSE:603233'
s FCF Yield % Range Over the Past 10 Years
Min: -1.07 Med: 3.54 Max: 24.02
Current: 20.61
During the past 13 years, the highest FCF Yield % of DaShenLin Pharmaceutical Group Co was 24.02%. The lowest was -1.07%. And the median was 3.54%.
SHSE:603233's FCF Yield % is ranked better than 92.22% of 681
companies
in the Healthcare Providers & Services industry
Industry Median: 1.83
vs SHSE:603233: 20.61
DaShenLin Pharmaceutical Group Co FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
DaShenLin Pharmaceutical Group Co FCF Yield % Related Terms
DaShenLin Pharmaceutical Group Co FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DaShenLin Pharmaceutical Group Co FCF Yield % Chart
DaShenLin Pharmaceutical Group Co FCF Yield % Competitor Comparison
For the Pharmaceutical Retailers subindustry, DaShenLin Pharmaceutical Group Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DaShenLin Pharmaceutical Group Co FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DaShenLin Pharmaceutical Group Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where DaShenLin Pharmaceutical Group Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DaShenLin Pharmaceutical Group Co (SHSE:603233) has a FCF Yield % of 20.61 as of Jul. 06, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on DaShenLin Pharmaceutical Group Co and its competitors. This is 482% above median its historical median of 3.54. According to the industry distribution chart, DaShenLin Pharmaceutical Group Co ranks #53 out of 681 companies in the Healthcare Providers & Services industry, placing it in the top 7.8%.
Is DaShenLin Pharmaceutical Group Co's FCF Yield % too high?
DaShenLin Pharmaceutical Group Co's current FCF Yield % of 20.61 is 482% above median its 10-year median of 3.54. The Healthcare Providers & Services industry median FCF Yield % is 1.83. DaShenLin Pharmaceutical Group Co's value of 20.61 is 1026.2% above this industry median. Based on the distribution chart, DaShenLin Pharmaceutical Group Co ranks #53 out of 681 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, DaShenLin Pharmaceutical Group Co has a GF Score™ of 95/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DaShenLin Pharmaceutical Group Co's FCF Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, DaShenLin Pharmaceutical Group Co ranks #53 out of 681 companies for FCF Yield %. This places DaShenLin Pharmaceutical Group Co in the top 8% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.83. DaShenLin Pharmaceutical Group Co's value of 20.61 is 1026.2% above this benchmark. While the company's 10-year median is 3.54 vs. the industry median of 1.83, DaShenLin Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.83, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DaShenLin Pharmaceutical Group Co's current FCF Yield % of 20.61 is 1026.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on DaShenLin Pharmaceutical Group Co and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DaShenLin Pharmaceutical Group Co's current FCF Yield % is 20.61, which is 482% above median its own 10-year median of 3.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaShenLin Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, DaShenLin Pharmaceutical Group Co (SHSE:603233) is currently considered Fairly Valued. The stock's GF Value™ is ¥18.75, compared to a current price of ¥17.20 — trading 8.3% below its estimated fair value. The current FCF Yield % is 20.61, which is 482% above median its 10-year median of 3.54 and 1026.2% above the Healthcare Providers & Services industry median of 1.83. DaShenLin Pharmaceutical Group Co's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For DaShenLin Pharmaceutical Group Co (SHSE:603233), the current FCF Yield % is 20.61 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DaShenLin Pharmaceutical Group Co (SHSE:603233) Overvalued in 2026?
Based on GuruFocus' analysis, DaShenLin Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥17.20 is trading 8.3% below its estimated GF Value™ of ¥18.75.
GuruFocus considers DaShenLin Pharmaceutical Group Co to be Fairly Valued.
Key valuation signals for SHSE:603233:
FCF Yield %: 20.61 (482% above median its 10-year median of 3.54)
GF Value™: ¥18.75 vs. price of ¥17.20 (8.3% below fair value)
Industry Position: 1026.2% above the Healthcare Providers & Services median (#53 of 681)
No single metric tells the full story. See the SHSE:603233 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DaShenLin Pharmaceutical Group Co Business Description
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail, and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.
95GF Score
Get the complete analysis for SHSE:603233
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603233 has been successfully added to your 
